Model Number 8637-40 |
Device Problems
Kinked (1339); Obstruction of Flow (2423)
|
Patient Problem
Complaint, Ill-Defined (2331)
|
Event Date 05/09/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id: 8781, serial# (b)(4), implanted: (b)(6) 2017, product type: catheter.
Product id: 8781, serial/lot #: (b)(4), ubd: 11-oct-2019, udi#: (b)(4).
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a healthcare provider (hcp) via a clinical study regarding a patient receiving hydromorphone 2.
0 mg/ml for a total dose of 0.
4563 mg/day and bupivacaine 30 mg/ml for a total dose of 6.
844 mg/day via an implantable pump for spinal pain.
It was reported during a scheduled pump pocket revision on (b)(6) 2018, surgical observation indicated a catheter kink was observed.
The catheter was freed from the scar tissue and reattached to the pump.
Other surgical intervention included the catheter kink was manually released on (b)(6) 2018.
The device diagnosis was catheter kink.
The outcome of the event resolved without sequelae on (b)(6) 2018.
The etiology of the event indicated the relationship of the event to the device or therapy was related and indicated the relationship of the event to the implant procedure was not related.
No further complications were reported/anticipated.
|
|
Manufacturer Narrative
|
Additional review determined that the previously reported information (pump pocket revision) pertains to manufacturer's report # 3004209178-2018-01757 [pump slanted forward during refill].
Additional information regarding that event will be reported under that manufacturing number.
This manufacturing report pertains to the following information: [catheter kink].
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from a healthcare provider via a clinical study reported the cause of the catheter kink was not determined.
The patient's baseline weight was (b)(6) lbs.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from a healthcare professional via clinical study indicated the patient was receiving hydromorphone 2.
0mg/ml for a total dose of 0.
4563mg/day and bupivacaine 30mg/ml for a total dose of 6.
844mg/day.
No further complications were reported.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|